These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 21220792

  • 1. [Lights off? Neurobiological and pharmacological aspects of the melatonergic-serotonergic synergism].
    Sumegi A, Somoskovi C.
    Neuropsychopharmacol Hung; 2010 Dec; 12(4):469-75. PubMed ID: 21220792
    [Abstract] [Full Text] [Related]

  • 2. Agomelatine: new drug. Adverse effects and no proven efficacy.
    Prescrire Int; 2009 Dec; 18(104):241-5. PubMed ID: 20020562
    [Abstract] [Full Text] [Related]

  • 3. Melatonergic drugs in clinical practice.
    Hardeland R, Poeggeler B, Srinivasan V, Trakht I, Pandi-Perumal SR, Cardinali DP.
    Arzneimittelforschung; 2008 Dec; 58(1):1-10. PubMed ID: 18368944
    [Abstract] [Full Text] [Related]

  • 4. Agomelatine as chronopsychopharmaceutics restoring circadian rhythms and enhancing resilience to stress: a wishfull thinking or an innovative strategy for superior management of depression?
    Jakovljević M.
    Psychiatr Danub; 2011 Mar; 23(1):2-9. PubMed ID: 21448091
    [Abstract] [Full Text] [Related]

  • 5. [Melatoninergic antidepressant valdoxan].
    Arushanian ÉB.
    Eksp Klin Farmakol; 2011 Mar; 74(7):41-5. PubMed ID: 21894769
    [Abstract] [Full Text] [Related]

  • 6. Agomelatine in depressive disorders: its novel mechanisms of action.
    Srinivasan V, Zakaria R, Othman Z, Lauterbach EC, Acuña-Castroviejo D.
    J Neuropsychiatry Clin Neurosci; 2012 Mar; 24(3):290-308. PubMed ID: 23037643
    [Abstract] [Full Text] [Related]

  • 7. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R, Cardinali DP.
    Int J Neurosci; 2009 Mar; 119(6):821-46. PubMed ID: 19326288
    [Abstract] [Full Text] [Related]

  • 8. Pathophysiology of depression: role of sleep and the melatonergic system.
    Srinivasan V, Pandi-Perumal SR, Trakht I, Spence DW, Hardeland R, Poeggeler B, Cardinali DP.
    Psychiatry Res; 2009 Feb 28; 165(3):201-14. PubMed ID: 19181389
    [Abstract] [Full Text] [Related]

  • 9. [Clinical experiences with agomelatine. The inner ear has to be synchronized again].
    MMW Fortschr Med; 2010 Mar 11; 152(10):46-7. PubMed ID: 20380235
    [No Abstract] [Full Text] [Related]

  • 10. Addressing circadian rhythm disturbances in depressed patients.
    Lam RW.
    J Psychopharmacol; 2008 Sep 11; 22(7 Suppl):13-8. PubMed ID: 18753278
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Depression--sequelae of disturbed circadian rhythm. Rapid onset of effect supports treatment success].
    MMW Fortschr Med; 2010 Oct 07; 152(40):48-9. PubMed ID: 21049646
    [No Abstract] [Full Text] [Related]

  • 13. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.
    Kasper S, Hamon M.
    World J Biol Psychiatry; 2009 Oct 07; 10(2):117-26. PubMed ID: 19255935
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Disturbances of diurnal phase markers, behavior, and clock genes in a rat model of depression; modulatory effects of agomelatine treatment.
    Højgaard K, Christiansen SL, Bouzinova EV, Wiborg O.
    Psychopharmacology (Berl); 2018 Mar 07; 235(3):627-640. PubMed ID: 29151193
    [Abstract] [Full Text] [Related]

  • 16. [Agomelatine: the first "melatoninergic" antidepressant].
    Bánki MC.
    Neuropsychopharmacol Hung; 2006 Oct 07; 8(3):105-12. PubMed ID: 17211046
    [Abstract] [Full Text] [Related]

  • 17. [Depression: possible etiology: circadian dysregulation].
    MMW Fortschr Med; 2012 Jan 19; 154(1):82-3. PubMed ID: 22642014
    [No Abstract] [Full Text] [Related]

  • 18. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine.
    Pandi-Perumal SR, Moscovitch A, Srinivasan V, Spence DW, Cardinali DP, Brown GM.
    Prog Neurobiol; 2009 Aug 19; 88(4):264-71. PubMed ID: 19454302
    [Abstract] [Full Text] [Related]

  • 19. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development.
    de Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P, Muñoz C, Millan MJ.
    Nat Rev Drug Discov; 2010 Aug 19; 9(8):628-42. PubMed ID: 20577266
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.